Ken Griffin Venus Concept Inc. Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.45 - $1.57 $14,184 - $49,487	31,521 New	31,521 $14,000
Q3 2021 Nov 15, 2021	SELL	$1.79 - $3.27 $58,980 - $107,746	-32,950 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.72 - $3.19 $28,660 - $53,154	16,663 Added 102.31%	32,950 $102,000
Q1 2021 May 17, 2021	BUY	$1.73 - $3.33 $28,176 - $54,235	16,287 New	16,287 $38,000
Q1 2020 May 15, 2020	SELL	$2.35 - $8.2 $32,305 - $112,725	-13,747 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.76 - $8.85 $37,941 - $121,660	13,747 New	13,747 $65,000

Ticker VERO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 65,459,600
Market Cap $20.9M
Description
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device us...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.